Back to search

Long‐term evaluation of recombinant interferon α2b in the treatment of patients with hepatitis B e antigen‐negative chronic hepatitis B in Taiwan

Data up to Jan 2025

Published2001
Citations18
References32

Total Citations Per Year

Abstract

References (32)

Avoiding false positives with PCR

1989 • 3,564 citations

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1981 • 3,549 citations

A One-Year Trial of Lamivudine for Chronic Hepatitis B

1998 • 1,779 citations

MUTATION PREVENTING FORMATION OF HEPATITIS B e ANTIGEN IN PATIENTS WITH CHRONIC HEPATITIS B INFECTION

1989 • 1,210 citations

Vertical Transmission of Hepatitis B Antigen in Taiwan

1975 • 1,022 citations

Effect of Alpha-Interferon Treatment in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis B

1993 • 1,011 citations

Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy

1991 • 827 citations

Mutations in the Precore Region of Hepatitis B Virus DNA in Patients with Fulminant and Severe Hepatitis

1991 • 536 citations

Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis befficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B …

1999 • 481 citations

Efficacy of Long-Term Lamivudine Monotherapy in Patients With Hepatitis B e Antigen–Negative Chronic Hepatitis B

2000 • 365 citations

Chronic hepatitis in HBsAg carriers with serum HBV-DNA and Anti-HBe

1986 • 334 citations

Postnatal Infectivity of Hepatitis B Surface Antigen-Carrier Mothers

1983 • 284 citations

Long-term follow-up of patients with anti-HBe/HBV DNA-positive chronic hepatitis B treated for 12 months with lamivudine

2000 • 246 citations

A controlled trial of interferon with or without prednisone priming for chronic hepatitis B

1992 • 242 citations

The long-term outcome of interferon-α treated and untreated patients with HbeAg-negative chronic hepatitis B

2001 • 231 citations

Natural course and response to interferon of chronic hepatitis B accompanied by antibody to hepatitis B e antigen

1989 • 229 citations

Hepatitis B virus unable to secrete e antigen and response to interferon in chronic hepatitis B

1993 • 183 citations

A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum

1997 • 178 citations

A randomized controlled trial of lymphoblastoid interferon-α in patients with chronic hepatitis B lacking HBeAg

1992 • 161 citations

Long-term follow-up of anti-HBe-positive chronic active hepatitis B

1988 • 138 citations

Interferon alfa-2b treatment of HBeAg negative/serum HBV DNA positive chronic active hepatitis type B

1990 • 136 citations

Multiple viral infection as the most common cause of fulminant and subfulminant viral hepatitis in an area endemic for hepatitis B: Application and limitations of the polymerase chain reaction

1994 • 125 citations

Anti-HBe-positive chronic hepatitis B with HBV-DNA in the serum response to a 6-month course of lymphoblastoid interferon

1992 • 108 citations

Use of Interferon for Prevention of Hepatocellular Carcinoma in Cirrhotic Patients with Hepatitis B or Hepatitis C Virus Infection

1999 • 93 citations

Low level hepatitis B viremia detected by polymerase chain reaction accompanies the absence of HBe antigenemia and hepatitis in hepatitis B virus carriers.

1997 • 46 citations

Pilot study of combination therapy with ribavirin and interferon alfa for the retreatment of chronic hepatitis B e antibody-positive patients

2000 • 30 citations

Cytotoxic T lymphocyte responses and CTL epitope escape mutation in HBsAg, anti-HBe positive individuals

2000 • 29 citations

Low-dose recombinant interferon therapy in anti-HBe-positive chronic hepatitis B in Asian Indians

1998 • 17 citations

Interferon treatment with or without oral ganciclovir in HBeAg‐negative chronic hepatitis B: a randomized study

2000 • 13 citations

Low level wild-type and pre-core mutant hepatitis B viruses and hbeAg negative reactivation of chronic hepatitis B

1999 • 13 citations

Response to Interferon-α2a in Patients with e Antigen-Negative Chronic Hepatitis B

1997 • 13 citations

Lamivudine therapy for chronic hepatitis B: Is longer duration of treatment better?

2000 • 13 citations

Cited By (0)

Loading...
Long‐term evaluation of recombinant interferon α2b in the treatment of patients with… (2001) – Journal of Viral Hepatitis | Metascience Observatory Explorer